HMCC attracts investor Holland Capital for further growth
Amsterdam, 2 November 203 – Investment firm Holland Capital is investing in HMCC Medical Group (HMCC), a provider that offers remote support for primary care. The investment is led by Holland Capital, in partnership with Weijenberg Invest. With this investment, HMCC can further develop its services and technologies.
Remote Healthcare
The Dutch healthcare system is facing challenges due to an aging population and a shortage of healthcare professionals. This highlights the need for solutions like HMCC that optimize resources while improving the quality of care. HMCC is committed to improve the accessibility of general practitioner practices and clinics. By deploying a professional medical team, HMCC relieves the pressure on practices and medical staff, allowing them to focus on patient care. HMCC’s team consists of experienced medical assistants, triage personnel, and nurses who provide remote expert advice to patients. They carefully assess the urgency of medical inquiries and facilitate effective communication. The on-site assistant in the general practitioner’s office can then fully concentrate on providing physical care to patients.
Innovative Growth
With the investment, HMCC can further develop and expand its services and technologies to better meet the growing demand for remote healthcare.
“The approach of HMCC contributes to improving the accessibility of the general practitioner’s office for patients and reducing the workload at the practice. We are excited to invest in a company that plays a central role in efficiently facilitating remote healthcare,” says Jan-Frens van Giessel, partner at Holland Capital. Following the investment in the healthcare platform HealthConnected in 2020, this is Holland Capital’s second investment focused on efficiency and digitalization in primary care.
Patrick Eliasar, CEO of HMCC, says, “Thanks to the investment from Holland Capital, we can expand our services and further develop the technology to meet the growing needs of remote healthcare. The investment also allows us to move forward with a much clearer vision of the future of healthcare, where the role of remote patient care becomes not only essential for general practitioners, hospitals, and clinics but also for pharmacies, for example.”
About HMCC
HMCC is a leading medical contact center specializing in improving the accessibility of general practitioner practices. With a team of experienced professionals, HMCC provides solutions that contribute to quality healthcare and remote care. Dozens of general practitioner practices and clinics already use HMCC’s services.
About Holland Capital
For the past 40 years, Holland Capital has responsibly and successfully invested in over 180 promising companies. With a clear investment strategy, the firm is active in attractive growth markets, including Healthcare, Technology, and Agrifood. The experienced and engaged investment team understands what entrepreneurship entails. They aim for an open, sustainable, and professional relationship with the management teams of the companies they invest in, with the common goal of achieving growth. Holland Capital is supported by a broad network of successful entrepreneurs and has offices in Amsterdam and Düsseldorf.
Holland Venture invests in LivAssured to support further development of the NightWatch
A groundbreaking detection system for nocturnal epileptic attacks Amsterdam, 20 September 2018 - Investment company Holland Venture invests with Oost NL and Health Innovations Fund in LivAssured, which developed the revolutionary NightWatch in collaboration...
Holland Venture closed a new fund to support innovation in healthcare
Amsterdam, 20 September 2018 – Holland Venture closed a new healthcare innovation fund which will invest in approx. 10 Dutch healthcare start-ups, active in the field of medical devices, diagnostics and digital health. The aim of the fund is to support entrepreneurs...
Investeerder Holland Venture start nieuw fonds voor innovaties in de zorg
Amsterdam, 20 september 2018 – Holland Venture is een nieuw zorginnovatie fonds gestart dat de komende jaren gaat investeren in circa 10 innovatieve ondernemers in de zorg. Het doel van het fonds is om ondernemers die actief zijn op het gebied van medical devices,...
Holland Venture investeert in LivAssured voor ontwikkeling NightWatch
Amsterdam, 20 september 2018 – Investeringsmaatschappij Holland Venture investeert met Oost NL en Health Innovations Fund in het bedrijf LivAssured, dat de revolutionaire NightWatch heeft ontwikkeld in samenwerking met neurologen en patiëntenverenigingen. De...
Quantib presents revolutionary software for dementia and MS diagnosis support and tracking
Rotterdam, The Netherlands – August 1st 2018. Quantib, market leader in artificial intelligence tools for radiology, released a major upgrade of their dementia and MS diagnosis support software Quantib™ ND. A substantial list of new features supporting the diagnosis...
Quantib presenteert revolutionaire software voor ondersteuning en tracking van dementie en MS-diagnose
Rotterdam, Nederland, 1 augustus 2018 - Quantib, marktleider in hulpmiddelen voor kunstmatige intelligentie voor radiologie, heeft een belangrijke upgrade van hun dementie en MS-diagnose-ondersteuningssoftware Quantib ™ ND uitgebracht. Een substantiële lijst met...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl